CannabisNewsBreaks – Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology

Cannabinoid-based pharmaceuticals company Teewinot Life Sciencess employs its patent-protected CANNSYNTHESIS® technology to biosynthesize cannabinoids for the large-scale manufacture of pharmaceutically pure cannabinoids. An article discussing the company’s technology reads: “Apart from THC and CBD, many of the 111 or so cannabinoids found in the cannabis plant are produced in minute quantities. Production by extraction is thus prohibitively costly, meaning that most cannabinoids have not been available for research and therapeutic applications. The CANNSYNTHESIS® platform has changed that paradigm, however, since it allows for the efficient production of cannabinoids in kilogram quantities. Teewinot’s CANNSYNTHESIS® has taken the production of cannabinoids from the lab to clinical settings, since the technology can deliver consistent and controlled dosages. Buoyed by its successes, the company continues to work with leading universities and pharmaceutical companies to provide novel patient therapies.”

To view the full article, visit

About Teewinot Life Sciences Corporation

Teewinot Life Sciences Corporation is an international cannabinoid biopharmaceutical company focused on advanced pharmaceutical research and product development. Teewinot’s novel platform manufacturing technology enables the production and delivery of products containing cannabinoids, cannabinoid prodrugs, and cannabinoid analogs.  With headquarters in Tampa, Florida, and subsidiaries, Teewinot Technologies Ltd. in Ireland and Teewinot Laboratories, Inc. in Canada, The Teewinot Group’s revolutionary technologies and intellectual property portfolio represent a breakthrough in creating safe and standardized cannabinoids. For more information, visit the company’s website at

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

Leave a Reply